Arteriolar involvement in the microvascular lesions of diabetic retinopathy: Implications for pathogenesis

Microcirculation

Volumn 14, Issue 1, 2007, Pages 25-38

  Gardiner, Tom A ^a   Archer, Desmond B ^a   Curtis, Tim M ^a   Stitt, Alan W ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Arterioles; Diabetes microvascular complications; Diabetic retinopathy; Microvascular pathology; Retina

Indexed keywords

ARTERIOLE; BLINDNESS; DEVELOPED COUNTRY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE DURATION; HUMAN; HYPERGLYCEMIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETINA BLOOD VESSEL; REVIEW;

ANIMALS; ARTERIOLES; DIABETIC RETINOPATHY; HUMANS; RETINAL VESSELS;

ANIMALIA;

EID: 33847261189     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680601072123     Document Type: Review

References (102)

1. Akagi, Y., Kador, P. F., Kuwabara, T. and Kinoshita, J. H. (1983) Aldose reductase localization in human retinal mural cells. Invest Ophthalmol Vis Sci, 24, pp. 1516-1519.
2. Alder, V. A., Su, E. N., Yu, D. Y. and Cringle, S. (1998) Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy. Aust N Z J Ophthalmol, 26, pp. 141-148.
3. Amemiya, T. and Bhutto, I. A. (2001) Retinal vascular changes and systemic diseases: Corrosion cast demonstration. Ital J Anat Embryol, 106, pp. 237-244.
4. Anderson, H. R., Stitt, A. W., Gardiner, T. A. and Archer, D. B. (1994) Stereological estimation of Weibel-Palade bodies in the retinal vasculature of normal and diabetic dogs. Curr Eye Res, 13, pp. 705-710.
5. Anderson, H. R., Stitt, A. W., Gardiner, T. A. and Archer, D. B. (1995) Diabetic retinopathy: Morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments. Br J Ophthalmol, 79, pp. 1120-1123.
6. Antonetti, D. A., Lieth, E., Barber, A. J. and Gardner, T. W. (1999) Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol, 14, pp. 240-248.
7. Armulik, A., Abramsson, A. and Betsholtz, C. (2005) Endothelial/pericyte interactions. Circ Res, 97, pp. 512-523.
8. Ashton, N. (1953) Arteriolar involvement in diabetic retinopathy. Br J Ophthalmol, 37, pp. 282-292.
9. Ashton, N. (1974) Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. Br J Ophthalmol, 58, pp. 344-366.
10. Ballantyne, A. J. and Loewenstein, A. (1943) Diseases of the retina: The pathology of diabetic retinopathy. Trans Ophthalmol Soc UK, 63, pp. 95-115.
11. Baskin, E., Balkanci, F., Cekirge, S., Sener, C. and Saatci, U. (1999) Renal vascular abnormalities in Bardet-Biedl syndrome. Pediatr Nephrol, 13, pp. 787-789.
12. Beltramo, E., Pomero, F., Allione, A., D'Alu, F., Ponte, E. and Porta, M. (2002) Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations. Diabetologia, 45, pp. 416-419.
13. Benjamin, L. E., Hemo, I. and Keshet, E. (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by pdgf-b and vegf. Development, 125, pp. 1591-1598.
14. Bjarnegard, M., Enge, M., Norlin, J., Gustafsdottir, S., Fredriksson, S., Abramsson, A., Takemoto, M., Gustafsson, E., Fassler, R. and Betsholtz, C. (2004) Endothelium-specific ablation of pdgfb leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development, 131, pp. 1847-1857.
15. Boyd-White, J. and Williams Jr., J. C. (1996) Effect of cross-linking on matrix permeability: A model for age-modified basement membranes. Diabetes, 45, pp. 348-353.
16. Bresnick, G. H., Davis, M. D., Myers, F. L. and de Venecia, G. (1977) Clinicopathologic correlations in diabetic retinopathy, II: Clinical and histologic appearances of retinal capillary microaneurysms. Arch Ophthalmol, 95, pp. 1215-1220.
17. Chakravarthy, U. and Gardiner, T. A. (1999) Endothelium-derived agents in pericyte function/dysfunction. Prog Retin Eye Res, 18, pp. 511-527.
18. Chen, J., Brodsky, S. V., Goligorsky, D. M., Hampel, D. J., Gross, S. S. and Goligorsky, M. S. (2002) Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res, 90, pp. 1290-1298.
19. Chibber, R., Molinatti, P. A., Wong, J. S., Mirlees, D. and Kohner, E. M. (1994) The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes, 43, pp. 758-763.
20. Chowdhury, T. A., Hopkins, D., Dodson, P. M. and Vafidis, G. C. (2002) The role of serum lipids in exudative diabetic maculopathy: Is there a place for lipid lowering therapy?. Eye, 16, pp. 689-693.
21. Cogan, D. G. and Kuwabara, T. (1967) The mural cell in perspective. Arch Ophthalmol, 78, pp. 133-139.
22. Coles, W. H. (1994) Hypertension and retinal vessels. Heart Dis Stroke, 3, pp. 304-308.
23. Cox, O. T., Simpson, D. A., Stitt, A. W. and Gardiner, T. A. (2003) Sources of pdgf expression in murine retina and the effect of short-term diabetes. Mol Vis, 9, pp. 665-672.
24. 2+ uptake in rat retinal microvascular smooth muscle. Diabetologia, 46, pp. 1252-1259.
25. Curtis, T. M. and Scholfield, C. N. (2004) The role of lipids and protein kinase cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev, 20, pp. 28-43.
26. Darland, D. C., Massingham, L. J., Smith, S. R., Piek, E., Saint-Geniez, M. and D'Amore, P. A. (2003) Pericyte production of cell-associated vegf is differentiation-dependent and is associated with endothelial survival. Dev Biol, 264, pp. 275-288.
27. DCCT (1993) Hypoglycemia in the diabetes control and complications trial: The diabetes control and complications trial research group. Diabetes, 46, pp. 271-286.
28. Engerman, R. L. and Kern, T. S. (1984) Experimental galactosemia produces diabetic-like retinopathy. Diabetes, 33, pp. 97-100.
29. Engerman, R. L. and Kern, T. S. (1995) Retinopathy in animal models of diabetes. Diabetes Metab Rev, 11, pp. 109-120.
30. Fong, D. S., Sharza, M., Chen, W., Paschal, J. F., Ariyasu, R. G. and Lee, P. P. (2002) Vision loss among diabetics in a group model health maintenance organization (HMO). Am J Ophthalmol, 133, pp. 236-241.
31. Fong, D. S., Aiello, L., Gardner, T. W., King, G. L., Blankenship, G., Cavallerano, J. D., Ferris 3rd, F. L. and Klein, R. (2004) Retinopathy in diabetes. Diabetes Care, 27:1, pp. S84-S87.
32. Fruttiger, M. (2002) Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci, 43, pp. 522-527.
33. Funk, R. H. (1997) Blood supply of the retina. Ophthalmic Res, 29, pp. 320-325.
34. Gardiner, T. A., Stitt, A. W., Anderson, H. R. and Archer, D. B. (1994) Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br J Ophthalmol, 78, pp. 54-60.
35. Gardiner, T. A., Anderson, H. R. and Stitt, A. W. (2003) Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol, 201, pp. 328-333.
36. Gardiner, T. A., Gibson, D. S., de Gooyer, T. E., de la Cruz, V. F., McDonald, D. M. and Stitt, A. W. (2005) Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol, 166, pp. 637-644.
37. Gardner, T. W., Antonetti, D. A., Barber, A. J., LaNoue, K. F. and Nakamura, M. (2000) New insights into the pathophysiology of diabetic retinopathy: Potential cell-specific therapeutic targets. Diabetes Technol Ther, 2, pp. 601-608.
38. Garner, A., Ashton, N., Tripathi, R., Kohner, E. M., Bulpitt, C. J. and Dollery, C. T. (1975) Pathogenesis of hypertensive retinopathy: An experimental study in the monkey. Br J Ophthalmol, 59, pp. 3-44.
39. Garner, A. (1993) Histopathology of diabetic retinopathy in man. Eye, 7, pp. 250-253.
40. Grunwald, J. E., Riva, C. E., Brucker, A. J., Sinclair, S. H. and Petrig, B. L. (1984) Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology, 91, pp. 1447-1452.
41. 2-breathing on retinal blood flow in normals and in patients with background diabetic retinopathy. Curr Eye Res, 3, pp. 239-241.
42. Grunwald, J. E., Riva, C. E., Baine, J. and Brucker, A. J. (1992) Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci, 33, pp. 356-363.
43. Hammes, H. P., Lin, J., Renner, O., Shani, M., Lundqvist, A., Betsholtz, C., Brownlee, M. and Deutsch, U. (2002) Pericytes and the pathogenesis of diabetic retinopathy. Diabetes, 51, pp. 3107-3112.
44. Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res, 37, pp. 614-636.
45. Hoffmann, J., Feng, Y., Hagen, F vom, Hillenbrand, A., Lin, J., Erber, R., Vajkoczy, P., Gourzoulidou, E., Waldmann, H., Giannis, A., Wolburg, H., Shani, M., Jaeger, V., Weich, H. A., Preissner, K. T., Hoffmann, S., Deutsch, U. and Hammes, H. P. (2005) Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J, 19, pp. 2035-2036.
46. Hohman, T. C., Nishimura, C. and Robison Jr., W. G. (1989) Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp Eye Res, 48, pp. 55-60.
47. Ishikawa, K., Uyama, M. and Asayama, K. (1983) Occlusive thromboaortopathy (takayasu's disease): Cervical arterial stenoses, retinal arterial pressure, retinal microaneurysms and prognosis. Stroke, 14, pp. 730-735.
48. Kador, P. F., Akagi, Y., Terubayashi, H., Wyman, M. and Kinoshita, J. H. (1988) Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol, 106, pp. 1099-1102.
49. Kador, P. F., Takahashi, Y., Wyman, M. and Ferris 3rd, F. (1995) Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol, 113, pp. 352-354.
50. Kalfa, T. A., Gerritsen, M. E., Carlson, E. C., Binstock, A. J. and Tsilibary, E. C. (1995) Altered proliferation of retinal microvascular cells on glycated matrix. Invest Ophthalmol Vis Sci, 36, pp. 2358-2367.
51. Kern, T. S. and Engerman, R. L. (1994) Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr Eye Res, 13, pp. 863-867.
52. Kern, T. S. and Engerman, R. L. (1995) Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res, 60, pp. 545-549.
53. Kern, T. S. and Engerman, R. L. (1996) A mouse model of diabetic retinopathy. Arch Ophthalmol, 114, pp. 986-990.
54. King, G. L., Goodman, A. D., Buzney, S., Moses, A. and Kahn, C. R. (1985) Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest, 75, pp. 1028-1036.
55. Klein, R., Klein, B. E. and Moss, S. E. (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care, 15, pp. 1875-1891.
56. Kohner, E. M., Dollery, C. T., Paterson, J. W. and Oakley, N. W. (1967) Arterial fluorescein studies in diabetic retinopathy. Diabetes, 16, pp. 1-10.
57. Kohner, E. M. and Dollery, C. T. (1970) Fluorescein angiography of the fundus in diabetic retinopathy. Br Med Bull, 26, pp. 166-170.
58. Kohner, E. M. and Henkind, P. (1970) Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol, 69, pp. 403-414.
59. Kohner, E. M., Patel, V. and Rassam, S. M. (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes, 44, pp. 603-607.
60. Kristinsson, J. K., Gottfredsdottir, M. S. and Stefansson, E. (1997) Retinal vessel dilatation and elongation precedes diabetic macular edema. Br J Ophthalmol, 81, pp. 274-278.
61. Kuwabara, T. and Cogan, D. G. (1960) Studies of retinal vascular patterns. Arch Ophthalmol, 64, pp. 124-131.
62. Kuwabara, T. and Cogan, D. G. (1965) Retinal vascular patterns, Vii: acellular change. Invest Ophthalmol, 4, pp. 1049-1064.
63. Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellstrom, M., Backstrom, G., Fredriksson, S., Landegren, U., Nystrom, H. C., Bergstrom, G., Dejana, E., Ostman, A., Lindahl, P. and Betsholtz, C. (2003) Endothelial pdgf-b retention is required for proper investment of pericytes in the microvessel wall. Genes Dev, 17, pp. 1835-1840.
64. Linskens, M. H., Harley, C. B., West, M. D., Campisi, J. and Hayflick, L. (1995) Replicative senescence and cell death. Science, 267, p. 17.
65. Ljubimov, A. V., Burgeson, R. E., Butkowski, R. J., Couchman, J. R., Zardi, L., Ninomiya, Y., Sado, Y., Huang, Z. S., Nesburn, A. B. and Kenney, M. C. (1996) Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem, 44, pp. 1469-1479.
66. Miller, S. A., Stevens, T. S. and de Venecia, G. (1976) De novo lesions in presumed ocular histoplasmosis-like syndrome. Br J Ophthalmol, 60, pp. 700-712.
67. Miyamoto, K. and Ogura, Y. (1999) Pathogenetic potential of leukocytes in diabetic retinopathy. Semin Ophthalmol, 14, pp. 233-239.
68. Mizutani, M., Kern, T. S. and Lorenzi, M. (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest, 97, pp. 2883-2890.
69. Moser, L. A., Simpson, D. E. and Young, D. D. (1989) Retinal macroaneurysms: The natural history in four patients. Optom Vis Sci, 66, pp. 877-883.
70. Mott, J. D., Khalifah, R. G., Nagase, H., Shield 3rd, C. F., Hudson, J. K. and Hudson, B. G. (1997) Nonenzymatic glycation of type iv collagen and matrix metalloproteinase susceptibility. Kidney Int, 52, pp. 1302-1312.
71. Neuenschwander, H., Julia, C., Wyman, M. and Kador, P. F. (1995) Endothelial changes in galactose-fed dogs. Curr Eye Res, 14, pp. 319-322.
72. Norton, E. W. (1981) Doyne memorial lecture, 1981: Fluorescein angiography, twenty years later. Trans Ophthalmol Soc U K, 101, pp. 229-233.
73. Padayatti, P. S., Jiang, C., Glomb, M. A., Uchida, K. and Nagaraj, R. H. (2001) High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr Eye Res, 23, pp. 106-115.
74. Petrovic, V. and Bhisitkul, R. B. (1999) Lasers and diabetic retinopathy: The art of gentle destruction. Diabetes Technol Ther, 1, pp. 177-187.
75. Pournaras, C. J., Riva, C. E., Tsacopoulos, M. and Strommer, K. (1989) Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res, 49, pp. 347-360.
76. Provis, J. M. (2001) Development of the primate retinal vasculature. Prog Retinal Eye Res, 20, pp. 799-821.
77. Robison Jr., W. G., Kador, P. F., Akagi, Y., Kinoshita, J. H., Gonzalez, R. and Dvornik, D. (1986) Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes, 35, pp. 295-299.
78. Robison Jr., W. G., Nagata, M., Laver, N., Hohman, T. C. and Kinoshita, J. H. (1989) Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci, 30, pp. 2285-2292.
79. Roodhooft, J. M. (2002) Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol, 483, pp. 19-25.
80. Roy, S., Maiello, M. and Lorenzi, M. (1994) Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest, 93, pp. 438-442.
81. Saint-Geniez, M. and D'Amore, P. A. (2004) Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol, 48, pp. 1045-1058.
82. Schmetterer, L. and Wolzt, M. (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia, 42, pp. 387-405.
83. Sharma, N. K., Gardiner, T. A. and Archer, D. B. (1985) A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol, 100, pp. 51-60.
84. Spranger, J. and Pfeiffer, A. F. (2001) New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes, 109, pp. S438-S450.
85. Srivastava, S., Ramana, K. V., Tammali, R., Srivastava, S. K. and Bhatnagar, A. (2006) Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes, 55, pp. 901-910.
86. Stitt, A. W., Anderson, H. R., Gardiner, T. A. and Archer, D. B. (1994) Diabetic retinopathy: Quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol, 78, pp. 133-137.
87. Stitt, A. W., Gardiner, T. A. and Archer, D. B. (1995) Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol, 79, pp. 362-367.
88. Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., Archer, D. B. and Vlassara, H. (1997) Advanced glycation end products (ages) co-localize with age receptors in the retinal vasculature of diabetic and of age-infused rats. Am J Pathol, 150, pp. 523-531.
89. Stitt, A. W., Simpson, D. A., Boocock, C., Gardiner, T. A., Murphy, G. M. and Archer, D. B. (1998) Expression of vascular endothelial growth factor (vegf) and its receptors is regulated in eyes with intra-ocular tumours. J Pathol, 186, pp. 306-312.
90. Stitt, A. W., Gardiner, T. A., Alderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., Thorpe, S. R. and Anderson, N. L. (2002) The age inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes, 51, pp. 2826-2832.
91. Stitt, A. W., Hughes, S. J., Canning, P., Lynch, O., Cox, O., Frizzell, N., Thorpe, S. R., Cotter, T. G., Curtis, T. M. and Gardiner, T. A. (2004) Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia, 47, pp. 1735-1746.
92. Sundberg, C., Kowanetz, M., Brown, L. F., Detmar, M. and Dvorak, H. F. (2002) Stable expression of angiopoietin-1 and other markers by cultured pericytes: Phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest, 82, pp. 387-401.
93. Tolentino, M. J., Miller, J. W., Gragoudas, E. S., Jakobiec, F. A., Flynn, E., Chatzistefanou, K., Ferrara, N. and Adamis, A. P. (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology, 103, pp. 1820-1828.
94. Tzekov, R. and Arden, G. B. (1999) The electroretinogram in diabetic retinopathy. Surv Ophthalmol, 44, pp. 53-60.
95. Uemura, A., Ogawa, M., Hirashima, M., Fujiwara, T., Koyama, S., Takagi, H., Honda, Y., Wiegand, S. J., Yancopoulos, G. D. and Nishikawa, S. (2002) Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest, 110, pp. 1619-1628.
96. UKPDS (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (ukpds 34). UK prospective diabetes study (UKPDS) group. Lancet, 352, pp. 854-865.
97. Hagen, F vom, Feng, Y., Hillenbrand, A., Hoffmann, S., Shani, M., Deutsch, U. and Hammes, H. P. (2005) Early loss of arteriolar smooth muscle cells: More than just a pericyte loss in diabetic retinopathy. Exp Clin Endocrinol Diabetes, 113, pp. 573-576.
98. Wilkinson-Berka, J. L., Babic, S., De Gooyer, T., Stitt, A. W., Jaworski, K., Ong, L. G., Kelly, D. J. and Gilbert, R. E. (2004) Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol, 164, pp. 1263-1273.
99. Wise, G. N. (1958) Arteriosclerosis secondary to retinal vein obstruction. Trans Am Ophthalmol Soc, 56, pp. 361-380.
100. Wong, T. Y. and McIntosh, R. (2005) Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull, 73, pp. 57-70.
101. Yanoff, M. (1966) Diabetic retinopathy. N Engl J Med, 274, pp. 1344-1349.
102. Yanoff, M. (1969) Ocular pathology of diabetes mellitus. Am J Ophthalmol, 67, pp. 21-38.